Regulatory compliance - December 9, 2014
AstraZeneca Scores Victory in Pay-for-Delay Case
In what could become a significant decision for the pharmaceutical industry, a jury in U.S. federal court found that AstraZeneca’s deal with Ranbaxy Laboratories to settle a patent fight over its heartburn medication Nexium did not violate antitrust laws. A group of pharmacies, wholesalers and insurers had sued over the agreement. As Bloomberg reported, this is the […]
Regulatory compliance - June 30, 2013
EU fines drug firms for delaying generics
The EU commission has filed Danish Lundbeck and eight other pharmaceutical firms for paying off rivals to delay production of generics. Photo. European Commissioner for Competition Joaquin Almunia during a press conference. The EU commission reached a decision in the several years’ long trial on Danish pharmaceutical firm Lundbeck for blocking generic versions of antidepressant drug […]
